Jazz Pharmaceuticals awards 1,605 RSUs to director
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hamill Laura reported acquisition or exercise transactions in this Form 4 filing.
Jazz Pharmaceuticals plc reported that director Laura Hamill received a grant of 1,605 restricted stock units, each representing one ordinary share, for no cash consideration. These units vest in full on July 23, 2027, subject to continuous service, bringing her direct holdings to 8,538 ordinary shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1 | 1,605 | $0.00 | $0.00 |
Footnotes (1)
- F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.
Key Figures
Key Terms
restricted stock units financial
contingent right financial
continuous service financial
Non-Employee Directors Stock Award Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Jazz Pharmaceuticals (JAZZ) disclose about Laura Hamill in this Form 4?
When do Laura Hamill’s Jazz Pharmaceuticals (JAZZ) restricted stock units vest?
Was Laura Hamill’s Jazz Pharmaceuticals (JAZZ) equity award made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.